SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2024 and 2023:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2024
Revenue	$	19,608,184		$	-		$	-		$	1,507,715		$	21,115,899
Cost of Sales		(12,034,348	)		-			(3,370	)		(744,906	)		(12,782,624	)
Gross Margin		7,573,836			-			(3,370	)		762,809			8,333,275
Operating Expenses		(1,793,188	)		(616,403	)		(1,076,095	)		(8,964,666	)		(12,450,351	)
Operating Income (Loss)		5,780,648			(616,403	)		(1,079,465	)		(8,201,857	)		(4,117,076	)
Other Income (Expense)		1,522			(2,947,968	)		(139,737	)		3,188,229			102,046
Net Income (Loss) Before Income Tax	$	5,782,170		$	(3,564,371	)	$	(1,219,202	)	$	(5,013,628	)	$	(4,015,030	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2023
Revenue	$	20,963,661		$	28,117		$	12,758		$	1,083,971		$	22,088,507
Cost of Sales		(13,915,144	)		(9,145	)		(54,529	)		(597,391	)		(14,576,209	)
Gross Margin		7,048,517			18,972			(41,771	)		486,580			7,512,298
Operating Expenses		(1,312,024	)		(468,679	)		(869,683	)		(7,734,566	)		(10,384,952	)
Operating Income (Loss)		5,736,493			(449,707	)		(911,454	)		(7,247,986	)		(2,872,654	)
Other Income (Expense)		47,363			(6,066,133	)		(593,994	)		(51,700,965	)		(58,313,729	)
Net Income (Loss) Before Income Tax	$	5,783,856		$	(6,515,840	)	$	(1,505,448	)	$	(58,948,951	)	$	(61,186,383	)
December 31, 2024
Cash and Restricted Cash	$	4,928,236		$	326,540		$	3,375,824		$	19,553,127		$	28,183,726
Total Assets		44,683,563			3,176,729			5,446,468			43,382,430			96,761,977
December 31, 2023
Cash and Restricted Cash	$	3,323,210		$	430,807		$	568,702		$	23,566,574		$	27,889,293
Total Assets		62,989,233			5,845,269			2,450,876			55,028,650			126,314,028